13Feb
13Feb
Aras to Celebrate 25 Years of Innovation at ACE 2025 in Boston
...2025 marks a major milestone as Aras celebrates 25 years of continuous innovation while looking ahead to AI-driven PLM, advanced digital thread strategies, and scalable transformation initiatives. ACE 2025 will explore how today’s industry pioneers are establishing seamless digital threads across the entire lifecycle to enhance resilience, efficiency, and long-term competitiveness. Read more >>
12Feb
DetraPel, Inc. Selects Charlotte for Headquarters, Manufacturing
DetraPel, Inc., a clean-tech advanced materials company, has chosen to relocate its headquarters and advanced manufacturing operations to Charlotte. The company will invest $3.5 million and bring more than 30 new jobs to Southwest Charlotte. Read more >>
12Feb
Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU
Corbus Pharmaceuticals Holdings, Inc., today announced that the abstract for its first-in-human dose escalation clinical study conducted in the United States and Europe (“Western study”) of CRB-701 (SYS6002) has been released. Read more >>
31Jan
RevBio Issued a Key Patent for its Regenerative Bone Adhesive Technology by the United States Patent and Trademark Office
The United States Patent and Trademark Office recently issued patent 12,178,937 entitled “Compositions and Methods for Adhesion to Surfaces,” which constitutes the 10th U.S. patent that covers the TETRANITE bone adhesive technology. This patent expands the protected technology to include injectable mineral-organic structural bone adhesive compositions that comprise alpha tricalcium phosphate. The issuance of this patent complements RevBio’s existing U.S. patent 11,638,777, which covers the method of repairing fractured bone using the aforementioned adhesive composition. These recently issued patents enlarge...
22Jan
Candidly Delivers on WEF’s 2025 Priority of “Investing in People” Through AI-Driven Student Debt and Savings Solutions
As global leaders gather for the 2025 World Economic Forum Annual Meeting to address critical challenges including workforce resilience, Candidly, the category leader in AI-driven debt and savings solutions exemplifies how innovative technologies can transform financial health. Candidly addresses the full lifecycle of education expenses and empowers workers to make simultaneous progress on paying down debt and building wealth. Through partnerships with leading employers and industry giants serving the workplace, Candidly's platform represents a model for how organizations can effectively...
22Jan
Candidly delivers next-gen benefit solutions for student debt and beyond
Candidly, the category leader in financial wellness benefits, partners with leading employers, recordkeepers, and financial services providers to deliver solutions that bring financial wellness, security, and wealth within reach — for everyone. Watch now >>
21Jan
Wines Most Inspiring People 2025: Marian Leitner-Waldman — Designing Wine for the Modern Consumer
The wine industry has been grappling with attracting younger generations for more than a decade. Marian Leitner-Waldman, co-founder and CEO of Archer Roose Wines, brought a fresh outsider’s perspective to this issue and developed an innovative approach to making wine a part of these consumers’ everyday lives. Read more >>
17Jan
Neuraly and Enigma Biomedical USA announce a Research License and Commercialization Option Agreement for PET Imaging Biomarker, PMI04
On January 16, 2025, Neuraly Inc., a wholly owned subsidiary of D&D Pharmatech Inc., and Enigma Biomedical USA, Inc., announced the signing of a research license and commercialization option agreement for PMI04, a PET (Positron Emission Tomography) imaging biomarker of neuroinflammation developed by Neuraly. Under the agreement, Enigma acquires an exclusive research license for PMI04, as well as the option to negotiate commercialization rights based on the research results. PMI04 is a PET imaging biomarker that selectively binds to CSF-1R...
17Jan